Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Nativia PEA is a palmitoylethanolamide supplement dosed at 600 mg of ultramicronized PEA per serving, taken as two small capsules with breakfast. It is aimed at nerve-related discomfort such as sciatica and burning feet, working on inflammation around the nerve rather than numbing the pain signal. The dose matches the one used in a 636-patient sciatica trial, and the brand cites 11 double-blind trials in which side effects matched placebo. It is slow-acting by design, building over about 60 days, so it suits people willing to commit to a two-month trial rather than expect quick relief.
In stockShips from Australia · duties may applyReturn policy
Buyers describe a slow build, with leg pain quieting and walking improving around day 50. Many value the clear study citations and dose transparency, and some on gabapentin or metformin report no interaction problems. The main complaints are nothing felt in the first two weeks and mild stomach upset at the start.
Nativia PEA is a supplement with 600 mg of ultramicronized palmitoylethanolamide (PEA) per serving. This is the dose used in a 636-patient sciatica trial. PEA is the only ingredient. It contains no magnesium stearate, seed oils or dyes.
PEA works on the inflammation around the nerve rather than dulling the pain signal. It is slow-acting by design and builds over 60 days, with nothing to wear off. A serving is two small capsules taken with breakfast.
Side effects matched placebo across 11 double-blind trials. There are no known clinically meaningful drug interactions, so it can be taken alongside prescriptions. A 60-day map in the box shows when to expect results and when to judge them.